Sacituzumab Govitecan in Patients With Solid Tumor
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of sacituzumab govitecan in patients
with unresectable, locally advanced or metastatic solid tumor